top of page
News & Events
3 Tactics That Guided Me Through the Pandemic
BrainsWay CEO and President Christopher von Jako discusses his perspectives leading a medical device company amid the pandemic....
May 19, 2021
Ringing the bell for mental health
Highlighting the Nasdaq bell-ringing event for BrainsWay and CEO and President, as well as local Lynnfield resident, Christopher von...
May 7, 2021
BrainsWay to Report First Quarter 2021 Financial Results on May 20, 2021
CRESSKILL, N.J. and JERUSALEM, Israel, May 6, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader...
May 6, 2021
BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Of
BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer CRESSKILL, N.J. and JERUSALEM,...
May 5, 2021
BrainsWay Announces Social Media Sweepstakes to Celebrate Mental Health Awareness Month
The Sweepstakes, demonstrating how Deep Transcranial Magnetic Stimulation (Deep TMS) can fit into an average day, offers participants a...
May 4, 2021
BrainsWay to Ring NASDAQ Closing Bell to Highlight May as Mental Health Awareness Month
CRESSKILL, N.J. and JERUSALEM, May 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a...
May 3, 2021
BrainsWay Announces Launch of Noninvasive Treatment for Smoking Addiction to U.S. Providers
Patients in areas across the country now have access to Deep Transcranial Magnetic Stimulation (Deep TMS) therapy as an aid for...
Apr 29, 2021
A Message for Anyone with a Treatment-Resistant Mental Illness
Kelly Dunn gives a personal account of her complications and hardships of living with treatment-resistant mental illness, how Deep TMS...
Apr 28, 2021
Could TMS Be Among Your Best Drug-Free Treatments for Depression?
Breanna Hushaw and Kelly Dunn outline their battles with depression and OCD (respectively), and discuss how the process of getting...
Apr 28, 2021
Treating Depression in 3 Minutes
BrainsWay’s Theta Burst protocol further expands the company’s toolset for treating major depressive disorder (MDD) and offers a shorter,...
Apr 27, 2021
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressiv
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder Shorter Protocol Further...
Apr 26, 2021
FDA clears three-minute depression treatment with Brainsway’s Theta Burst
BrainsWay’s Theta Burst protocol further expands the company’s toolset for treating major depressive disorder (MDD) and offers a shorter,...
Apr 26, 2021
BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS)
The FDA cleared technology is a noninvasive treatment for depression, OCD, and smoking addiction CRESSKILL, N.J. and JERUSALEM, Israel,...
Apr 14, 2021
Psychiatry Clinic Treats Brain with Magnetic Impulses
Sujit Varma of PsyFi TMS explains the benefits of Deep TMS and how he uses this non-invasive, insurance-covered technology to treat...
Apr 9, 2021
The COVID-19 Pandemic: Helping Those Who Suffer in Silence
Sandhya Prashad, MD is medical director at Houston Ketamine Therapeutics and Houston Deep Transcranial Magnetic Stimulation (TMS) Therapy...
Mar 26, 2021
BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights
Conference call to be held tomorrow, March 25, 2021, at 8:30 AM ET CRESSKILL, N.J. and JERUSALEM, Israel, March 24, 2021 (GLOBE NEWSWIRE)...
Mar 24, 2021
(Interview) BrainsWay Aims to Treat COVID-Caused Depression by “Jumpstarting” Brain
BrainsWay CEO Christopher von Jako discusses how Deep TMS is used to treat neurological conditions such as depression and...
Mar 23, 2021
BrainsWay to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021
CRESSKILL, N.J., March 11, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced...
Mar 11, 2021
bottom of page